SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)
$12.98 -0.67 (-4.9084%)
Analysed SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) News Sources
Syndax (SNDX) Sales Nearly Doubled, So Why Did The Stock Fall?
12-08-2026
yahoo.com
Syndax Announces Participation in September Investor Conferences
01-09-2026
yahoo.com
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04-09-2026
yahoo.com
Syndax Announces Topline Results from MAXPIRe Phase 2 Trial of Axatilimab in Idiopathic Pulmonary Fibrosis
12-10-2026
yahoo.com
Syndax Pharmaceuticals stock tumbles on failed IPF trial
12-10-2026
yahoo.com
SNDX Stock Slumps 16% After-Hours — What’s Driving The Selloff?
12-10-2026
stocktwits.com
Syndax Pharmaceuticals (SNDX) Is Down 7.2% After Axatilimab IPF Trial Misses Endpoint Has The Bull Case Changed?
13-10-2026
yahoo.com
Syndax Pharmaceuticals Stock Plunges. A Failed Trial Deals Blow to Growth Plans.
13-10-2026
yahoo.com
Syndax Stock Falls 16% as Phase II Fibrosis Study Misses Primary Goal
14-10-2026
yahoo.com
Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List
15-10-2026
yahoo.com
What is the current price of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)?
The current price of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) is $12.98.
SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) since the previous trading day is $-0.67.
SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) since the previous trading day is -4.9084%.
What is the most recent average sentiment score for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)?
The most recent average sentiment score for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)?
The most recent sentiment for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) is .
SEC-8K** Filing Available For SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.